Background Gefapixant is a P2X3 receptor antagonist that has shown promise for the treatment
of refractory and unexplained chronic cough. The aim of this study was to evaluate the …

Background The 2014 Zaire Ebola virus outbreak highlighted the need for a safe, effective
vaccine with a rapid onset of protection. We report the safety and immunogenicity of the …

Background and objectives Gefapixant has previously demonstrated efficacy in the treatment
of refractory chronic cough at a high daily dose. The current investigations explore efficacy …

Background: In the primary analysis of the DRIVE-SHIFT trial, switching to doravirine/lamivudine/tenofovir
disoproxil fumarate (DOR/3TC/TDF) maintained suppression of HIV-1 through …

Purpose This analysis assesses clinical characteristics of patients with refractory chronic
cough (RCC) or unexplained chronic cough (UCC) enrolled in a phase 2 study to better …

Background Studies have shown that steroids can improve kidney survival and decrease the
risk of proteinuria in patients with Immunoglobulin A nephropathy, but the overall benefit of …

We first described the 2019 novel coronavirus infection in 10 children occurring in areas other
than Wuhan. The coronavirus diseases in children are usually mild and epidemiological …

Endogenous steroids and numerous environmental agents have potent effects on mammary
development and carcinogenesis. Locally produced cytochrome P450 enzymes that modify …

The unsatisfactory reversibility of zinc (Zn) metal anodes seriously hinders their wide practical
application. This corresponds to two major issues, namely the notorious dendrite growth …

Pancreatic cancer is one of the most lethal malignancies worldwide. Although the standard
of care in pancreatic cancer has improved, prognoses for patients remain poor with a 5-year …